Cinemark Holdings, Inc. - 10-Q Summary (Q2 2008)
Business Context and Reporting Period
This report covers the quarterly period ended June 30, 2008. Cinemark Holdings, Inc. is a leading motion picture exhibitor operating theatres in the U.S., Canada, and various Latin American countries. The company operates two reportable segments: U.S. and International. As of July 31, 2008, there were 107,455,096 shares of common stock outstanding.
Key Financial Metrics
| Metric | Six Months Ended June 30, 2008 | Six Months Ended June 30, 2007 |
|---|---|---|
| Total Revenues | $858.3 million | $818.1 million |
| Net Income | $20.8 million | $166.1 million |
| Diluted EPS | $0.19 | $1.66 |
| Operating Cash Flow | $139.0 million | $166.6 million |
| Adjusted EBITDA | $184.0 million | $177.1 million |
| Total Debt (Long-term + Current) | $1,530.6 million | $1,523.7 million |
| Cash and Equivalents | $396.3 million | $338.0 million |
Material Changes vs. Prior Period
- Revenue Growth: Total revenues increased 4.9% year-over-year, driven by a 7.4% increase in average ticket prices and a 5.8% increase in concession revenue per patron. This growth occurred despite a 1.7% decline in total attendance.
- Profitability Decline: Net income dropped significantly from $166.1 million to $20.8 million. The prior year included a one-time $210.8 million gain from the National CineMedia (NCM) transaction and a $9.2 million gain from the Fandango transaction, neither of which occurred in 2008.
- Impairment Charges: Impairment of long-lived assets decreased substantially to $5.8 million in 2008 from $56.8 million in 2007. The 2007 charge was largely due to goodwill impairment triggered by the NCM transaction.
- Operating Costs: Theatre operating costs as a percentage of revenue remained stable at approximately 74.9% in 2008 compared to 74.6% in 2007. General and administrative expenses increased to $45.1 million from $37.1 million due to higher incentive compensation and legal fees.
Guidance, Outlook, and Risks
- Capital Expenditures: The company estimates remaining capital expenditures of approximately $87 million for 200 domestic screens and $9 million for 27 international screens committed as of June 30, 2008.
- Dividends: The company declared a quarterly cash dividend of $0.18 per share on August 7, 2008, payable September 12, 2008.
- Debt Management: The company repurchased $10 million of its 9 3/4% senior discount notes in March 2008. It maintains approximately $150 million in available borrowing capacity under its revolving credit facility.
- Market Risks:
- Interest Rate Risk: A 100 basis point increase in market rates would increase annual interest expense by approximately $6.0 million. The company has hedged $500 million of variable rate debt via interest rate swaps.
- Foreign Currency: A 10% unfavorable change in exchange rates would decrease the net book value of international investments by approximately $40 million.
- Seasonality: Results are heavily influenced by the timing of major film releases, with peak seasons typically in summer and the holiday period.
Investor Verification Checklist
- One-Time Gains: Verify the exclusion of the $210.8 million NCM gain and $9.2 million Fandango gain from 2007 results when analyzing year-over-year profitability trends.
- Attendance Trends: Monitor the 1.7% decline in attendance; revenue growth is currently driven by price increases rather than volume.
- Debt Covenants: Review the dividend restrictions in the indenture for the 9 3/4% senior discount notes and the senior secured credit facility to ensure continued compliance.
- Capital Commitments: Confirm the funding sources for the estimated $96 million in remaining capital expenditures for new theatre development.
- Foreign Exchange Impact: Assess the sensitivity of international segment results (approx. 22% of total revenue) to currency fluctuations, particularly in Brazil and Mexico.